tebu-bio’s SilenciX cell lines presented at STS Meeting 2008 - Weimar

Oct. 27, 2008 - PRLog -- SilenciX cell lines are target-specific silenced cells, produced as ready-to-use validated models, thus enabling researchers to focus on their experimental work without having to first construct the tools required for their studies. The innovative technology is based on non-viral transfections of non-integrative vectors. The episomal vectors are maintained tethered to the host chromosomes, at a very low copy number per cell.

Guarantee of target-specific knock-down at RNA level is at least 70%, cell lines produced so far mostly show over 85% silencing. Design of shRNAs is powered by the new DSIR algorithm for the prediction of RNAi efficacy and off-target blast screening.

The SilenciX technology allows long-term studies, consistent large cell supplies and high reproducibility in experiments, with no additional stress related to cell transfections, making it a reliable tool for target validation and drug discoveries in Life Sciences.

Dr Ali el Bayâ of tebu-bio (co-sponsors of the meeting) will be presenting SilenciX on Wednesday October 29th.

Further information and recent publications mentioning the SilenciX cell lines can be found at  http://www.tebu-bio.com/file/thematic/92/

# # #

tebu-bio is an expert in the supply and distribution of reagents for Life Sciences research in Europe and has its own R&D laboratories which provides contract services. Our tebu-bio.com catalogue provides access to the most innovative range of products.